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For nearly two decades, microbial genomics has been mainly
performed in research settings, providing much information on
the virulence and pathogenic mechanisms at play during
bacterial infections, shedding light on the evolution of micro-
organisms, and allowing the identiﬁcation of new targets for
diagnosis, treatment, and/or vaccines [1]. Thanks to the recent
availability of different high-throughput sequencing methods,
bacterial genomes may now be sequenced in less than a week,
at a cost similar to that of other medical diagnostic procedures
routinely used in university hospitals, such as magnetic
resonance imaging and positron emission tomography. Thus,
bacterial genomics is now entering diagnostic laboratories, and
it is time to summarize, in a special issue, the challenges,
difﬁculties and opportunities for clinical microbiologists during
this shift towards microbial genomics.
As outlined by Bertelli et al. [2], this shift, mainly triggered
by novel technologies, is mainly based on the ‘dirty genome’
concept, i.e. that raw genome sequences generally include
>90% of all genes, allowing downstream proteomics to be
performed on >90% of the encoded proteins [3]. Moreover,
most of the genes missed with unassembled genomes are
repeated elements, such as transposases and recombination
hot spots, that are of little relevance for medical applications of
bacterial genomics. The proof of the ‘dirty genome’ concept
was provided during the recent enterohaemorrhagic Escheri-
chia coli outbreak, as combined efforts demonstrated the
feasibility of rapid genome sequencing in less than a week for
the E. coli O104:H4 epidemic strain [16]. It also demonstrated
the usefulness of the obtained raw genomic sequence for: (i)
developing a speciﬁc molecular diagnostic test; (ii) obtaining
information on virulence factors encoded on the genome; (iii)
indirectly assessing the antibiotic susceptibility by looking at its
resistome (antibiotic resistance-encoding genes); and (iv)
understanding the evolutionary history of the strain. All of
these different applications of rapid genome sequencing (Fig. 1)
are extensively discussed in the ﬁrst article of this special issue,
after a brief description of currently available sequencing
technologies. Moreover, future challenges of clinical bacterial
genomics, as well as clinical metagenomics and single-cell
genomics, are also discussed in this extensive review [2].
In the second review article, Sentausa and Fournier describe
the advantages of genomics for bacterial taxonomy in terms of
the quality and quantity of information that can be derived
from genome sequences [4]. However, it is important to: (i)
deﬁne which genes should be use to infer consensus trees that
are taxonomically reliable; and (ii) precisely assess the added
value of indexes such as the average nucleotide identity in
comparison with the current reference standard, DNA–DNA
hybridization. As outlined by Sentausa and Fournier, the
exponentially increasing number of genomes will ease the use
of the average nucleotide identity and other whole taxoge-
nomic indicators to assign a given species [4]. Nevertheless,
despite the amount of information provided by genome
sequencing, bacterial genomics should clearly not be consid-
ered as providing complete strain characterization, and
taxonomy should still rely on some complementary phenotypic
tests.
In the article by Price et al., the different applications of
genomics in clinical microbiology are described by using
Staphylococcus aureus as an example [5]. For this pathogen,
genomics is very promising, given the large number of S. aureus
genomes available for comparison, and will probably provide
rapid simulatneous access to data on the presence of virulence
factors such as superantigen-encoding genes, on the presence
of mecA genes, and on the genotype. Information on the last of
these has already been derived from genomic sequences to
infer epidemiological relationships between different S. aureus
carriers and to analyse methicillin-resistant S. aureus outbreaks
[6,7]. However, for S. aureus, such outbreak investigations
have, to date, been only retrospective, owing to the amount of
data to be analysed and the current lack of automated
bioinformatic pipelines allowing rapid inference of possible
transmission events.
The investigation of outbreaks by the use of bacterial
genome sequencing is also reviewed extensively in the fourth
article of this special issue [8], with Mycobacterium tuberculosis
as an example. Whole genome sequencing showed better
resolution than all typing approaches previously used by
mycobacteriologists, including the more recent mycobacterial
interspersed repetitive-unit variable-number tandem repeat
typing approach [9,10]. In the review article by Walker et al.,
the usefulness of single-nucleotide polymorphisms to infer the
directionality of transmission events within a given outbreak is
nicely presented, allowing readers who are unaccustomed with
this ﬁeld to become familiar with the ‘evolution by descent’
paradigm [10].
Finally, after these four review articles, infectious disease
specialists and clinical microbiologists will be highly interested
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in the original article written by Andersson et al., reporting the
direct sequencing of various bacterial genomes directly from
DNA extracted and ampliﬁed from a vaginal sample [11]. The
genomes sequenced included those of three pathogens:
Mycoplasma hominis, Gardnerella vaginalis, and Chlamydia tracho-
matis [11]. The latter pathogen merits a speciﬁc comment, as
retrieved genomic data were sufﬁcient to allow its genotyping.
Indeed, despite a relatively low average coverage of 2.6x, as
many as 85% of the whole C. trachomatis sequence was
obtained, and 23 single-nucleotide polymorphisms were iden-
tiﬁed, allowing classiﬁcation of the strain at the genotype level
[11]. This original article thus demonstrates the feasibility of
performing bacterial genomics directly on clinical samples,
even in the presence of several species (at least distantly
related species). Such direct genome sequencing from clinical
samples opens the application of clinical genomics to strict
intracellular bacteria and any other fastidious microorganisms.
With this special issue on microbial genomics of medical
importance, our intention is to stimulate the implementation
of genomics in clinical microbiology laboratories by providing a
clear demonstration of the feasibility of the ‘raw genome
sequencing’ or ‘dirty genome’ approaches and its many future
clinical applications (Fig. 1). However, automated pipelines for
bioinformatic analyses are needed to enable the acquisition,
within 48–72 h, of genome-derived data that are directly useful
for clinical microbiologists, infectious diseases specialists, or
epidemiologists, and that will ad ﬁnem beneﬁt patient care.
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to the expansion and the progress of medical bacterial genomics.
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the ﬁgure, three raw genome sequences are compared to corre-
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sented in white in the inner circle. The green genome is that of Vibrio
cholerae O1 strain 2010EL-1786, isolated during the recent cholera
outbreak that occurred in Haiti (15). The brown genome is that of the
Escherichia coli O104:H4 strain LB226692, isolated during the large
German EHEC outbreak (16). Finally, the blue genome is the dirty
genome of Parachlamydia acanthamoebae strain Hall coccus (3), a strain
isolated during the investigation of an outbreak of fever (17).
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